Looking forward to next week, when Thalocan Research Innovations CEO Eric Zudak heads to 2026 AAD Innovation Academy, a unique program packed with the latest breakthroughs in dermatology.

The AAD Innovation Academy delivers cutting-edge clinical insights and meaningful networking moments. And when it comes to cutting edge, TRI is proud to deliver TRICOA, the first eCOA designed specifically to meet the complex requirements of dermatology scales, scoring and outcomes. This new BYOD application improvesthe study experience for sites and patients, accelerates real-time data availability and provides crucial transparency for Sponsors.

Engineered with decentralized studies in mind and implementing feedback from trialists to address common eCOA pain-points, TRICOA offers unprecedented speed and flexibility – redefining the standards in Dermatology endpoint data collection.

Click HERE for more information about TRICOA.